News | 06.25.20
Medtronic’s Global SYMPLICITY Registry Shows Sustained Lower Blood Pressure After Renal Denervation
June 25, 2020—Medtronic reported new data from the Global SYMPLICITY registry (GSR), which showed that renal denervation (RDN) with the Medtronic Symplicity RDN system significantly reduced blood pressure (BP) in uncontrolled hypertension patients out to 3 years independent of antihypertension medication burden.
News | 06.04.20
FDA Clears Transit Scientific’s XO Score Angioplasty Scoring and Cutting Platform
June 4, 2020—Transit Scientific announced FDA clearance for the XO Score percutaneous transluminal angioplasty (PTA) scoring sheath platform for use in iliac, iliofemoral, popliteal, infrapopliteal, and renal artery disease plus synthetic and/or native arteriovenous hemodialysis fistula.
News | 05.06.20
Getinge Introduces Larger-Diameter Advanta V12 Balloon-Expandable Covered Stent to Treat Iliac Artery Disease
May 6, 2020—Getinge announced the commercial introduction of a larger-diameter Advanta V12 balloon-expandable covered stent, which expands from 12 to 16 mm, to treat iliac arterial occlusive disease.
News | 03.13.20
News | 01.22.20
Consensus Statement Published on the Use of Intravenous Iodinated Contrast Media in Patients With Kidney Disease
January 22, 2020—A consensus statement from the American College of Radiology and the National Kidney Foundation addresses the use of intravenous iodinated contrast media in patients with kidney disease.
News | 11.13.19
European Societies Publish Consensus Document on Follow-Up After Revascularization for PAD
November 14, 2019—A consensus document from European societies on the follow-up of patients after revascularization for peripheral artery disease (PAD) was published by Maarit Venermo, MD, et al in the European Journal of Vascular and Endovascular Surgery (2019;58:641–653).
News | 09.28.19
REMEDIAL III Shows UFR-Guided Hydration Reduces Risk of Contrast-Induced Kidney Injury in High-Risk Patients
September 29, 2019—The Cardiovascular Research Foundation (CRF) announced that results from the REMEDIAL III trial were presented by Carlo Briguori, MD, at TCT 2019, the 31st annual Transcatheter Cardiovascular Therapeutics scientific symposium, which is sponsored by CRF and held September 25–29 in San Francisco, California.
News | 06.16.19
Merit Medical Acquires Brightwater Medical
June 17, 2019—Merit Medical Systems, Inc. announced that it has acquired Brightwater Medical, Inc. The transaction consists of a $35 million upfront payment and potential earn-out payments of up to $15 million based on receipt of CE Mark approval and achievement of future sales targets.
News | 05.21.19
Studies Support Medtronic's Renal Denervation System in High-Risk Hypertensive Patients
May 22, 2019—Medtronic announced that late-breaking clinical data from a physician-sponsored clinical trial using the company's Symplicity renal denervation (RDN) system were presented at EuroPCR held May 21–24 in Paris, France.
News | 03.19.19
News | 02.12.19
BD's WavelinQ 4-F endoAVF System Receives FDA 510(k) Clearance
February 13, 2019—BD (Becton, Dickinson and Company) announced that it has received FDA 510(k) clearance for its WavelinQ 4-F endoAVF system, which allows the creation of an arteriovenous (AV) fistula in either the ulnar artery and ulnar vein or the radial artery and radial vein in patients with end-stage renal disease (ESRD) on hemodialysis.
News | 01.15.19
Study Evaluates Strength of Evidence Underlying the AHA/ACC Guidelines on Treating Peripheral Vascular Disease
January 16, 2019—Findings from a study evaluating the evidence base supporting the American Heart Association (AHA)/American College of Cardiology (ACC) guidelines on peripheral vascular interventions (PVIs) were published by Partha Sardar, MD, et al online in Circulation: Cardiovascular Interventions. The investigators concluded that there is significant variation in the level of evidence (LOE) supporting various PVIs in the current guidelines.
News | 01.15.19
New Appropriate Use Criteria Address Peripheral Artery Interventions
January 16, 2019—The American College of Cardiology (ACC) announced that the "2018 Appropriate Use Criteria for Peripheral Artery Intervention" document was published by Steven R. Bailey, MD, et al online in Journal of the American College of Cardiology.
News | 11.07.18
FDA Approves SPYRAL HTN-ON MED Study of Medtronic's Symplicity Spyral RDN System
November 8, 2018—Medtronic announced FDA approval to begin a clinical trial to evaluate the company's Symplicity Spyral renal denervation (RDN) system in patients with uncontrolled blood pressure taking multiple antihypertensive medications.
News | 08.08.18
US Device Guide
This Device Guides offers a searchable, comprehensive listing of the available vascular interventional devices in the United States.
European Device Guide
This Device Guides offers a searchable, comprehensive listing of the available vascular interventional devices in Europe.